World Leader in

Cell Expansion & Rejuvenation


February 1, 2024

ExCellThera Announces Publication in Blood Highlighting the Potential for UM171 to Result in Efficient Stem Cell Expansion for Therapeutic Use

– Data expand on previously described mechanism of action and validate use of UM171 to create improved hematopoietic stem cell (HSC) therapies, including UM171 Cell Therapy – Company expects to initiate a Phase 3 study for UM171 Cell Therapy for the treatment of high and very high-risk acute leukemias and myelodysplasias in 2024 MONTREAL, February […]

Read more

About us

Who we are

ExCellThera is an advanced clinical-stage company specializing in cell expansion and engineering, providing molecules and bioengineering solutions to expand and modify various cell lines for use in innovative single-use curative therapies for patients with hematological malignancies and other diseases.

Learn more